Cargando…

Advanced health biotechnologies in Thailand: redefining policy directions

BACKGROUND: Thailand faces a significant burden in terms of treating and managing degenerative and chronic diseases. Moreover, incidences of rare diseases are rising. Many of these—such as diabetes, cancer, and inherited inborn metabolic diseases—have no definite treatments or cure. Meanwhile, advan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velasco, Román Pérez, Chaikledkaew, Usa, Myint, Chaw Yin, Khampang, Roongnapa, Tantivess, Sripen, Teerawattananon, Yot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564822/ https://www.ncbi.nlm.nih.gov/pubmed/23281771 http://dx.doi.org/10.1186/1479-5876-11-1

Ejemplares similares

Lessons drawn from research utilization in the maternal iodine supplementation policy development in Thailand
por: Tonmukayakul, Utsana, et al.
Publicado: (2012)

Selecting topic areas for developing quality standards in a resource-limited setting
por: Khampang, Roongnapa, et al.
Publicado: (2019)

Multi-criteria decision analysis for setting priorities on HIV/AIDS interventions in Thailand
por: Youngkong, Sitaporn, et al.
Publicado: (2012)

Government use licenses in Thailand: an assessment of the health and economic impacts
por: Yamabhai, Inthira, et al.
Publicado: (2011)

Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand
por: Yothasamut, Jomkwan, et al.
Publicado: (2010)

Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment
por: Youngkong, Sitaporn, et al.
Publicado: (2010)

Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE
por: Tantivess, Sripen, et al.
Publicado: (2017)

Using cost-effectiveness analyses to inform policy: the case of antiretroviral therapy in Thailand
por: Tantivess, Sripen, et al.
Publicado: (2006)

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
por: Tantai, Narisa, et al.
Publicado: (2014)

The economic costs of alcohol consumption in Thailand, 2006
por: Thavorncharoensap, Montarat, et al.
Publicado: (2010)

A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand
por: Leelahavarong, Pattara, et al.
Publicado: (2010)

Utilisation of evidence from Thailand’s National Health Examination Survey in policy development: finding the weakest link
por: Tantivess, Sripen, et al.
Publicado: (2019)

Systematic Review of Economic Evaluations of Preparedness Strategies and Interventions against Influenza Pandemics
por: Pérez Velasco, Román, et al.
Publicado: (2012)

The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh
por: Teerawattananon, Yot, et al.
Publicado: (2016)

Development of a Health Screening Package Under the Universal Health Coverage: The Role of Health Technology Assessment
por: Teerawattananon, Yot, et al.
Publicado: (2016)

Assessing the Accuracy and Feasibility of a Refractive Error Screening Program Conducted by School Teachers in Pre-Primary and Primary Schools in Thailand
por: Teerawattananon, Kanlaya, et al.
Publicado: (2014)

The economic impact of alcohol consumption: a systematic review
por: Thavorncharoensap, Montarat, et al.
Publicado: (2009)

How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings?
por: Teerawattananon, Yot, et al.
Publicado: (2016)

Maternal and child health voucher scheme in Myanmar: a review of early stage implementation
por: Pilasant, Songyot, et al.
Publicado: (2016)

What criteria do decision makers in Thailand use to set priorities for vaccine introduction?
por: Pooripussarakul, Siriporn, et al.
Publicado: (2016)

Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund
por: Teerawattananon, Yot, et al.
Publicado: (2013)

The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand
por: Teerawattananon, Yot, et al.
Publicado: (2008)

Scaling up health policies and services in low- and middle-income settings
por: Hanson, Kara, et al.
Publicado: (2010)

A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
por: Kumluang, Suthasinee, et al.
Publicado: (2019)

The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis
por: Katanyoo, Kanyarat, et al.
Publicado: (2021)

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand’s pharmaceutical benefit package
por: Anothaisintawee, Thunyarat, et al.
Publicado: (2012)

Historical development of the htasialink network and its key determinants of success
por: Teerawattananon, Yot, et al.
Publicado: (2018)

Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand
por: Pattanaphesaj, Juntana, et al.
Publicado: (2010)

Relationship between socioeconomic, demographic, health and social characteristics and ability to access reliable information on herbal and food supplements: analysis of Thai Health Literacy Survey 2019
por: Khampang, Roongnapa, et al.
Publicado: (2022)

Is it worth offering a routine laparoscopic cholecystectomy in developing countries? A Thailand case study
por: Teerawattananon, Yot, et al.
Publicado: (2005)

Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
por: Sangroongruangsri, Sermsiri, et al.
Publicado: (2018)

Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
por: Sangroongruangsri, Sermsiri, et al.
Publicado: (2019)

Cost-utility analysis of the screening program for early oral cancer detection in Thailand
por: Kumdee, Chutima, et al.
Publicado: (2018)

Economic impact of medical genetic testing on clinical applications in Thailand
por: Jittikoon, Jiraphun, et al.
Publicado: (2020)

Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand
por: Sangroongruangsri, Sermsiri, et al.
Publicado: (2021)

Cost-Utility Analysis of Molecular Testing for Tuberculosis Diagnosis in Suspected Pulmonary Tuberculosis in Thailand
por: Chitpim, Natthakan, et al.
Publicado: (2022)

Economic cost of patients with trisomy 13, 18, and 21 in a tertiary hospital in Thailand
por: Wongkrajang, Preechaya, et al.
Publicado: (2023)

Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6
por: Kapol, Nattiya, et al.
Publicado: (2016)

Cost-utility analysis of adjuvant imatinib treatment in patients with high risk of recurrence after gastrointestinal stromal tumour (GIST) resection in Thailand
por: Bussabawalai, Thanaporn, et al.
Publicado: (2019)

INADEQUATE PHYSICAL ACTIVITY ON HEALTHCARE EXPENDITURES AMONG MIDDLE AGE AND OLDER WORKING ADULTS IN THAILAND
por: Akksilp, Katika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e6ua6tdk1ee03mif2c52ri2b7h